Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial

We aimed to demonstrate whether coronary microvascular function is improved after ticagrelor administration compared to clopidogrel administration in STEMI subjects undergoing thrombolysis. MIRTOS is a multicentre study of ticagrelor versus clopidogrel in STEMI subjects treated with fibrinolysis. We...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	EuroIntervention 2021-02, Vol.16 (14), p.1163-1169
Hauptverfasser:	Hamilos, Michalis, Kanakakis, John, Anastasiou, Ioannis, Karvounis, Charalambos, Vasilikos, Vasilios, Goudevenos, John, Michalis, Lampros, Koutouzis, Michalis, Tsiafoutis, Ioannis, Raisakis, Konstantinos, Stakos, Dimitrios, Hahalis, George, Vardas, Panos
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Clopidogrel - adverse effects Fibrinolysis Humans Percutaneous Coronary Intervention Platelet Aggregation Inhibitors - therapeutic use ST Elevation Myocardial Infarction - drug therapy Thrombolytic Therapy Ticagrelor - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We aimed to demonstrate whether coronary microvascular function is improved after ticagrelor administration compared to clopidogrel administration in STEMI subjects undergoing thrombolysis. MIRTOS is a multicentre study of ticagrelor versus clopidogrel in STEMI subjects treated with fibrinolysis. We enrolled 335 patients
ISSN:	1774-024X 1969-6213
DOI:	10.4244/EIJ-D-20-00268